跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
硫酸氢氯吡格雷片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Clopidogrel Bisulfate Tablets
Approved
化学药品
Clopidogrel Bisulfate Tablets
ESSETI FARMACEUTICI SRL
🇨🇳 National Medical Products Administration
Approval Date
Feb 11, 2022
Approval ID
8DqcFRx7EKy
Company
ESSETI FARMACEUTICI SRL
Type
化学药品
Approval Details
Approval Id
8DqcFRx7EKy
Approval Number
国药准字HJ20220005
Generic Name
硫酸氢氯吡格雷片
Generic Name En
Clopidogrel Bisulfate Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
75mg(按C16H16ClNO2S 计)
Reg Date
2022-02-11
Expired Date
2027-02-10
Company Name
ESSETI FARMACEUTICI SRL
Production Company Name
NEURAXPHARM PHARMACEUTICALS S.L.
Company Detail Path
/organization/esseti-farmaceutici-srl
Production Company Detail Path
/organization/neuraxpharm-pharmaceuticals-s-l
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 11, 2022
Approval ID
8DqcFRx7EKy
Type
化学药品
Back to NMPA Approvals